Introduction {#s0001}
============

Hyperpolarization-activated cyclic nucleotide-gated channels (HCN) are a family of ion channels that have been extensively investigated for their roles in cardiac physiology.[@cit0001] Expressed predominantly in the nervous system and heart, 4 genes encoding HCN isoforms (HCN1--4) have been identified in mammals, which have differential tissue-specific expression and functionality. Functional channels are composed of 4 subunits that are arranged around a centrally located pore. HCN channels are permeable to Na^+^, K^+^ and Ca^2+^, and produce currents (known as I~f~ \[funny current\] in the heart and I~h~ in the nervous system) that have a variety of physiological functions, such as regulating the spontaneous depolarization of adult heart and nerve cells.[@cit0004] HCN4 and HCN2 are the most abundant isoforms in mammalian adult hearts and are distributed in all regions of the heart that undergo spontaneous firing (known as the cardiac conduction system).[@cit0006]

In addition to their well-characterized roles in adult tissues, several studies have reported that HCN4 and HCN2 are also expressed during early stages of both murine and chick embryogenesis.[@cit0007] For example, in mouse embryos, *HCN4* mRNA is first expressed in progenitors of the primary heart field during gastrulation, well before the heart begins to beat.[@cit0011] At the beginning of cardiac looping, it is asymmetrically expressed on the left side of the sinus venosus, but this asymmetry is reversed to the right side by the end of looping. Although HCN2 becomes the dominant isoform in the hearts of mouse neonates, HCN4 continues to be expressed in the developing heart, with its expression becoming progressively restricted to the cardiac conductive system.[@cit0011] Thus, in addition to its pacemaker function, HCN4 channels likely play an earlier role during the development of the embryonic heart. Because HCN4 knockout in mice leads to lethality before heart maturation, investigating novel embryonic roles of HCN4 has been challenging in animals with *in utero* development.[@cit0014]

To investigate a potential role for HCN4 channels during embryonic heart development, we took advantage of the externally developing vertebrate, *Xenopus laevis*. The underlying molecular mechanisms that direct heart development in *Xenopus* are highly conserved in all vertebrate organisms, making it an ideal translational system for mammalian models.[@cit0016] Importantly, unlike other model organisms, *Xenopus* embryos develop into tadpoles in the absence of a working circulatory system. Thus, it is possible to study early cardiovascular defects *in vivo* without the complication of secondary effects arising from a lack of circulation.

To create a functional heart during development, precursor cells need to differentiate into cardiac cell types, and tissues must be properly positioned within the body. In *Xenopus*, cardiac progenitors arise during gastrulation, and subsequently migrate as 2 bilateral patches along the lateral plate mesoderm to the ventral side of the body after the completion of neurulation.[@cit0021] As development proceeds, these 2 heart precursor fields merge at the ventral midline to create the primary heart tube. Before the bilateral precardiac fields merge, the expression of transcription factors such as *Nkx2.5* and *GATA-4* initiate the program for differentiation of the cardiac mesoderm. In addition to the signaling cascades that direct the differentiation of cardiac cells, patterning genes are simultaneously expressed that restrict, coordinate, and regulate the orientation and position of the heart in the body.[@cit0023] Specifically, the left-sided expression of genes such as *Xnr-1* and *Lefty*, establish an asymmetric field of gene expression between the left and right sides of an organism. Downstream effector genes like *Pitx* and *BMP-4*, reinforce this asymmetry and translate it to asymmetric morphogenesis during heart looping and chamber differentiation. HCN4\'s asymmetric expression the cardiac crescent in mice before heart tube formation[@cit0011] suggests that it might also regulate organ position within the body.

Further evidence suggesting a role for HCN4 during development is the fact that bioelectric signaling through ion channels has been shown to play a critical role during tissue formation, patterning, and organogenesis.[@cit0024] These signals establish membrane potentials and voltage gradients in cells through the unequal distribution of ions across the plasma membrane. Mutations in ion channels can lead to serious impairments during embryonic development. For example, mutating a Na^+^/K^+^-ATPase ion pump leads to abnormalities in heart tube extension, cardiomyocyte differentiation and cardiac function in zebrafish embryos.[@cit0033] Mutations in numerous ion channels induce a variety of channelopathies which manifest in human patients and model species as birth defects affecting various organs\' patterning.[@cit0035] Although most ion channels have been studied in the contexts of neurobiology and physiology, many are present during embryogenesis and could therefore have instructive patterning roles.[@cit0039]

Here we investigate the roles of HCN4 during embryogenesis, providing the first characterization of the expression profile of any of the HCN isoforms during *Xenopus* development and functionally investigating the consequences of altering HCN4 function during heart development. Both overexpressing HCN4 and injection of dominant-negative HCN4 mRNA disrupt the localization of key morphogenetic patterning genes, *Xnr-1, Lefty, Pitx2*, and *BMP-4*, resulting in hearts with incorrect positional orientation and morphology. Together, our data reveal a novel role for HCN4 channels in coordinating the distribution of critical morphogenetic control factors during heart development and directing normal heart morphology.

Results {#s0002}
=======

HCN4 is expressed asymmetrically in the developing heart field of Xenopus {#s0002-0001}
-------------------------------------------------------------------------

Because mice lacking functional HCN4 channels die during embryonic development between E9.5-E11.5, it has been postulated that this lethality results from atypical cardiac function.[@cit0014] While HCN4 function is essential for normal pacemaker activity, in both mice and chickens HCN4 is expressed very early in development, well before heart beating is initiated.[@cit0010] To investigate the possibility that HCN4 channels play an additional and earlier role during cardiogenesis, a spatio-temporal analysis via whole-mount *in situ* hybridization of *HCN4* mRNA expression was performed in *Xenopus laevis* during embryogenesis. *HCN4* transcripts were first robustly detected in the developing craniofacial region, in 2 bilateral stripes along the neural tube, and in the developing somites at the end of neurulation (NF stage 21, [Fig. 1A](#f0001){ref-type="fig"}). The craniofacial and somite expression pattern remained consistent throughout later tailbud and tadpole stages (NF stages 25--39, [Fig. 1A](#f0001){ref-type="fig"} and [B](#f0001){ref-type="fig"}). Expression in the notochord was discernible in tailbud stages (e,g., NF stages 25 and 27) and persisted throughout tadpole stages ([Fig. 1A--D](#f0001){ref-type="fig"}). Beginning at NF stage 26, *HCN4* transcripts were present in the presumptive heart region, where they were restricted to the left side of the developing cardiac field. Shortly thereafter expression became bilateral in the heart field (NF stage 27, [Fig. 1A](#f0001){ref-type="fig"}) but remained higher on the left side throughout the later stages of heart development ([Fig. 1B](#f0001){ref-type="fig"}). HCN4 expression was diffusely present in the myocardium at the completion of heart tube formation (NF stage 29/30, [Fig. 1B](#f0001){ref-type="fig"}). This myocardial expression remained throughout cardiac looping and chamber septation (NF stage 34 and stage 38/39, [Fig. 1B](#f0001){ref-type="fig"}). Unlike what has been observed in mice,[@cit0011] *HCN4* expression never became more highly expressed on the right side of the developing heart. As the sections in [Fig. 1C](#f0001){ref-type="fig"} illustrate, when cardiac differentiation is beginning during late tailbud stages, *HCN4* expression in the developing cardiac mesoderm was similar to what has been described for other primary heart field markers including: *Nkx2.5, MLC2a, Tbx5*, and *Tbx20*.[@cit0018] However, as differentiation and looping progress, *HCN4* expression was observed in both the myocardial tissue, as well as the septum transversum, the area where proepicardial precursor cells are located ([Fig. 1D](#f0001){ref-type="fig"}). The pattern of HCN4 expression observed at these stages is nearly identical to another marker of the septum transversurm, the epicardial-associated transcription factor *Tbx18* (NF stage 34, [Fig. 1B](#f0001){ref-type="fig"}).[@cit0042] Figure 1.*HCN4* expression during embryogenesis (A) *In situ* hybridization analysis reveals *HCN4* is expressed in the developing head and along the dorsal midline at the completion of neurulation embryos (NF stage 21 lateral and frontal views). At early tailbud stages, *HCN4* expression is observed primarily in the craniofacial region, in 2 stripes along the neural tube, and in the developing somites. This expression pattern is maintained as development progresses (NF stage 25, lateral and anterior/ventral views). At NF stage 26, *HCN4* mRNA begins to be expressed on the left side of the developing heart field (arrow; lateral and ventral views). Expression becomes bilateral beginning at NF stage 27/28 (arrows; lateral and ventral views) but remains more highly expressed on the left side of the body. Scale bars = 200μm. (B) As cardiogenesis progresses during tadpole stages (NF stages 29--39, lateral and ventral views, arrows denote heart), *HCN4* expression is diffusely present in the developing myocardium (outlined in yellow dashed lines/circles), but the highest expression is in the septum transversum where other proepicardial genes are expressed (*Tbx18*, NF stage 34). Scale bars = 200μm. (C,D) Histological sections confirm *HCN4* expression in the cardiac mesoderm at tailbud stages, and in the myocardium and proepicardial region in tadpole stages. *HCN4* expression can also be observed in the notochord and somites. Red lines in schematic diagrams denote the plane of section. Sections = 10μm, scale bars = 100μm. (E) Immunohistochemistry shows HCN4 protein is expressed at the completion of cardiac looping (NF stage 35) and is expressed throughout the entire ventricle of mature hearts (NF stage 46). Another important cardiac isoform, HCN2, is also found throughout the ventricle of mature hearts, similar to what has been described in mammalian systems. Transverse sections = 15 µm, scale bars = 100 µm. Schematic images are modified from Xenbase.[@cit0020]

We further confirmed HCN4s myocardial expression by examining the protein distribution in the heart via immunohistochemistry. HCN4 protein was expressed in the myocardium at NF stage 35, and later at NF stage 46 when heart maturation was complete ([Fig. 1E](#f0001){ref-type="fig"}). In both stages, HCN4 was robustly expressed throughout the myocardium. Interestingly, similar to what has been described in neonatal mouse and rat hearts,[@cit0043] the HCN2 protein was also highly expressed in the myocardium in NF stage 46 tadpoles ([Fig. 1E](#f0001){ref-type="fig"}). Although *HCN2* was robustly expressed in the developing nervous system and notochord at tailbud stages, *HCN2* channel expression was not detected in the developing heart region during early stages of cardiogenesis in Xenopus (between NF stages 26--34, Supplemental Figure 1). Thus, in addition to its established role in patterning the cardiac conduction system, the expression of HCN4 and not HCN2, in the developing heart field before the formation of a beating heart tube is consistent with additional embryonic roles during *Xenopus* cardiogenesis.

Functional expression of HCN4-WT and HCN4-DN(AAA) mutant in HEK293 cells {#s0002-0002}
------------------------------------------------------------------------

In humans, inherited mutations in the gene encoding *HCN4* have been shown to cause sinus node dysfunction. For example, patients who carry a missense D553N mutation[@cit0044] or a G480R point mutation[@cit0045] develop cardiac arrhythmias. G480 is one of the conserved amino acid residues within the "GYG" signature cation selectivity motif of the pore region across species. This motif is common to an array of potassium-permeable channels, and has previously been used to generate dominant negative constructs for other HCN isoforms ([Fig. 2A](#f0002){ref-type="fig"}).[@cit0046] We generated the triple amino acid mutant ("GYG" to "AAA"), and used voltage clamping in HEK293 cells, which do not have endogenous HCN expression, to characterize whether the HCN4-DN(AAA) mutant displayed a dominant-negative effect ([Fig. 2B](#f0002){ref-type="fig"}). Characteristic *I*~HCN4~ currents were generated in cells transfected with wildtype HCN4 in response to successive hyperpolarizing voltage steps, where larger voltage steps produced larger channel conductance. In contrast, in the HCN4-DN(AAA) expressing cells, the mutant channel showed little *I*~HCN4~ currents, with currents that were at the same magnitude as the negative vector control (pcDNA3, [Fig. 2B](#f0002){ref-type="fig"}). We then tested whether the HCN4-DN(AAA) could act as a true dominant-negative construct by co-transfecting it with the wildtype channel. If the HCN4-AAA mutant successfully integrated with wildtype subunits to form nonfunctional channels, then the currents observed with just HCN4-WT expression alone should be abolished. Indeed, when the mutant channel was co-expressed with the HCN4-WT channel (at 1:1 DNA ratio during transfection), the hybrid channel did not yield significant *I*~HCN4~ currents ([Fig. 2B--C](#f0002){ref-type="fig"}; n = 4, \*p \< 0.05). These data demonstrate that the HCN4-AAA mutant can result in a dominant negative effect. Thus, the HCN4-DN(AAA) mutation was subsequently used to manipulate channel function in *Xenopus* embryos. Figure 2.HCN4 dominant-negative effect test in HEK293 cells. (A) Sequence alignment of mouse HCN channels and other K^+^ channel examples that have a signature cation selectivity "GYG" motif at the channel pore region. (B) *I*~HCN~ currents were elicited by a stepwise hyperpolarization to −120 mV from a holding potential of −40 mV; and then normalized to membrane capacitance. Representative *I*~HCN4~ current traces recorded in HEK293 cells expressing HCN4-WT, HCN4-DN(AAA) mutant, both HCN4-DN(AAA)/HCN4-WT, or a vector control are shown. Transfection with HCN4-WT produced robust *I*~HCN4~ currents, whereas transfection with HCN4-DN(AAA) did not produce any current greater than the vector control. When HCN4-WT and HCN4-DN(AAA) were co-transfected, *I*~HCN4~ was abolished. (C) Summary data for the peak *I*~HCN4~ currents recorded from HEK293 cells expressing WT-HCN4, HCN4-AAA mutant, HCN4-AAA/WT-HCN4 or vector control, confirming the ability of HCN4-DN(AAA) to act as a dominant-negative construct. n = 4--5, \**p* \< 0.05.

Altering HCN4 leads to morphological and physiological defects in mature Xenopus hearts, but does not affect mesodermal or myocardial differentiation {#s0002-0003}
-----------------------------------------------------------------------------------------------------------------------------------------------------

To ascertain a possible role for HCN4 channels during the formation of the embryonic heart, we examined whether overexpressing wildtype HCN4 (HCN4-OE) or injecting the dominant-negative construct (HCN4-DN\[AAA\]) resulted in changes in heart morphology and physiology. For these experiments, we injected mRNAs encoding either the wild-type version of HCN4 (HCN4-\[OE\]) or a dominant-negative HCN4 mutant (HCN4-DN\[AAA\]) into one blastomere of 2-cell embryos. To determine if the sidedness of perturbation was important, membrane-bound RFP (mem-RFP) was co-injected as a lineage tracer to confirm location of expression in injected animals, and embryos were sorted for fluorescence on the left vs. the right side of the body. Heart morphology was examined after the completion of chamber septation (NF stage 46) using immunohistochemistry (IHC) for a Cardiac Troponin-T antibody (myocardial tissue) that allows visualization of mature heart structures. Both injection conditions induced abnormal cardiac phenotypes including twisted hearts, rotated hearts, unlooped hearts, and hearts with double ventricles ([Fig. 3Aii-v](#f0003){ref-type="fig"} respectively). Figure 3.Overexpression and injection of dominant-negative HCN4 mRNA induces aberrant heart morphology. (A) Mature NF stage 46 tadpole hearts were visualized by immunohistochemistry using a cardiac troponin-T antibody to detect mature cardiac muscle. In control tadpoles, the ventricle (V) and outflow tract (OFT) are readily visible with the atria located directly behind the ventricle (i). Altering HCN4 expression induced a variety of morphological defects including hearts that were twisted into the dorso-ventral (D-V) body axis (ii), hearts rotated in the same plane of the D-V axis (iii), unlooped hearts (iv), and double ventricle phenotypes (v). In twisted hearts (ii) the atria are no longer positioned behind the ventricle and can now be seen (At = atria). (B) Both injection conditions of the HCN4-DN(AAA) construct induced significantly higher percentages of morphological defects compared with uninjected tadpoles, whereas overexpression of HCN4 did not cause significant occurrences of malformed hearts χ^2^ = 58.174, df = 4, \* p \< 0.05; n = 75 embryos per condition across 3 biological replicates.

Although tadpoles with malformed hearts were seen when HCN4 was overexpressed, abnormal heart phenotypes were observed less frequently in HCN-OE injected animals than in the HCN4-DN(AAA) expressing tadpoles ([Fig. 3B](#f0003){ref-type="fig"}). In HCN4-DN(AAA) expressing animals, a significant percentage of mispatterned hearts was observed compared with stage-matched, uninjected tadpoles ([Fig. 3B](#f0003){ref-type="fig"}, χ^2^ = 55.709, df = 2, \* p \< 0.01). There was no statistical difference between left-sided expressing and right-side expressing animals in both HCN4-OE or HCN4-DN(AAA) conditions. Remarkably, irrespective of where the HCN4-OE (data not shown) or HCN4-DN(AAA) ([Fig. 4](#f0004){ref-type="fig"}) mRNAs were targeted in the tadpole, severely malformed hearts were observed, including animals without any detectable injected HCN4 in the ventral-anterior region where the heart is forming. Thus, altering the endogenous area of HCN4 function during early stages of cardiogenesis results aberrant heart phenotypes, even when injected mRNAs are expressed outside of the heart region in mature tadpoles. We conclude that HCN4 function is an important endogenous input into heart patterning, and that HCN4-dependent signaling functions at considerable distance (non-cell-autonomously). Figure 4.Inhibiting HCN4 function in different locations disrupts heart morphology. (A) Uninjected tadpoles have a clear chest cavity at NF stage 43/44, making the heart easily visible laterally (arrowhead, i). Hearts have normal ventricle and outflow tract morphology as seen via IHC for cardiac troponin-T antibody (ventral view, ii). The left eye is circled (white dashed line) in all images as a landmark. (B-D) HCN4-DN(AAA) injected embryos display a variety of heart defects, irrespective of the location of the lineage label membrane-bound RFP. Examples of tadpoles with mem-RFP located in the: heart (arrowhead, B, i), posterior flank (C, i), and dorsal region (D, i) of HCN4-DN(AAA) injected animals. White arrowheads denote position of heart. Ventral views of malformed heart phenotypes: symmetric midline hearts (B, ii), unlooped hearts (C, ii), and twisted hearts (D, ii). n = 18--31embryos per injection condition. Scale bars = 200 µm.

To examine whether the abnormal heart morphology resulted from the global mispatterning of embryonic tissues, the expression of several genes expressed during different stages of development was examined in HCN4-DN(AAA)-injected embryos (Supplemental Figure 2). The expression pattern of both *Xbra*, a panmesodermal gene activated during gastrulation,[@cit0047] and *Otx2*, a broad anterior structure marker expressed during gastrulation and neurulation,[@cit0048] was similar to uninjected control embryos (Supplemental Figure 2A). Similarly, *Nkx2.5* expression, which is an important cardiac field specification gene, was not affected by injection of HCN4-DN(AAA) during early cardiogenesis (NF stage 27), or later cardiac looping (NF stage 32). In addition, the presence of a myocardial-specific protein (CT3) in HCN4-altered animals ([Figs. 3](#f0003){ref-type="fig"} and [4](#f0004){ref-type="fig"}) provides further support that myocardial differentiation proceeded normally.

Since perturbing HCN4 channel function resulted in altered heart morphology, heart rates were analyzed to determine if cardiac conduction was also compromised ([Fig. 5](#f0005){ref-type="fig"}). There was no statistical difference between embryos with HCN4 overexpressed and uninjected, sibling embryos ([Fig. 5A](#f0005){ref-type="fig"}). However, all tadpoles injected with the HCN4-DN(AAA) channel had significantly faster heart rates (tachycardia) than uninjected sibling tadpoles confirming the ability of our injected-DN construct to modulate HCN4-dependent bioelectric events *in vivo* (Welch\'s test, \*p \< 0.05) ([Fig. 5B](#f0005){ref-type="fig"}). Figure 5.Injection of HCN4-DN(AAA) results in altered cardiac function. (A) Injecting wild-type HCN4 (HCN4-OE) into 2-cell embryos did not significantly alter heart rate. (B) Inhibiting HCN4 ion channel function (HCN4-DN\[AAA\]) resulted in significantly higher heart rates in all injection conditions (Welch\'s test, \*p \< 0.05). Dots represent outlier individuals who were greater or less than 1.5 times the upper and lower quartiles respectively. n = 30 embryos per condition across 3 biological replicates.

Altering HCN4 expression disrupts the distribution of left/right and cardiac morphogenetic patterning genes {#s0002-0004}
-----------------------------------------------------------------------------------------------------------

A critical step of creating functional organs during development is the final placement of organs inside the body cavity. All organs are dependent on surrounding tissues to provide the spatial cues needed to regulate growth, cell fate, and determine organ position. Previous research has demonstrated that altering the location of proteins that direct laterality decisions during development often results in the misplacement of organs. Because altering HCN4 channel function resulted in the formation of mispositioned, but properly differentiated myocardial tissue at swimming tadpole stages, and the endogenous channel is asymmetrically expressed in the heart field during early cardiogenesis, we investigated whether HCN4 interacts with canonical determinants of organ laterality during embryogenesis. Xnr-1 is one of the earliest regulators of laterality, and its left-sided expression is required for cardiogenesis to progress normally.[@cit0049] Therefore, we examined the expression pattern of *Xnr*-1 at stages when it is asymmetrically expressed in the lateral plate mesoderm at the completion of neurulation (NF stage 21) in animals injected with either the HCN4-OE or HCN4-DN(AAA) ([Fig. 6](#f0006){ref-type="fig"}). Injection of HCN4-DN(AAA) induced significantly higher percentages of abnormal, ectopic patterns of *Xnr-1* expression compared with uninjected sibling embryos, including: complete bilateral fields, right-sided expression, and punctate *Xnr-1* expression in both the lateral plate mesoderm as well as in dorsal region of the larvae (χ^2^ = 31.0207, df = 4, \*p \< 0.05). Interestingly, injecting the dominant-negative mRNA on the right-side of the body induced the highest percentage of abnormal *Xnr-1* expression phenotypes ([Fig. 6B](#f0006){ref-type="fig"}) with over 50% of HCN4-DN (right) injected embryos with abnormal ectopic *Xnr-1* expression, although this was not statistically different than injection on the left side of the body. While *Xnr-1* expression was occasionally altered in HCN4-OE injected animals, these were not statistically different from uninjected embryos ([Fig. 6B](#f0006){ref-type="fig"}). Figure 6.HCN4 helps coordinate the distribution of *Xenopus nodal-related 1* (*Xnr-1*) expression. (A) During normal development, *Xnr-1* is expressed exclusively in the left lateral plate mesoderm following the completion of neurulation as seen via *in situ* hybridization (NF stage 21, i). Both overexpression and injection of HCN4-DN(AAA) resulted in bilateral expression of *Xnr-1*, with the secondary *Xnr-1* field ranging from a small partial field containing few cells (yellow arrow, iii) to an equivalent right-sided field (white arrow, ii). In addition to generating a second field of *Xnr-1*, punctate dots of expression were observed along the fused neural tube (iii, red arrow) and flanks of embryos. These ectopic dots were found on both sides of embryos regardless of the presence of endogenous *Xnr-1* expression. Dorsal views, anterior at top. (B) While abnormal (bilateral, punctate, and right-sided reversed) expression was observed in all injection conditions, only HCN4-DN(AAA) injection caused a significant increase in abnormal phenotypes compared with uninjected embryos (χ^2^ = 31.0207, df = 4, \*p \< 0.05). n = 73--84 per condition across 3 biological replicates. OE = HCN4-OE, DN = HCN4-DN(AAA). Scale bars = 200 μm.

The ectopic, bilateral expression of *Xnr-1* ranged from small partial fields with few *Xnr-1* expressing cells ([Fig. 6A iii, yellow arrowhead](#f0006){ref-type="fig"}) to complete *Xnr-1* fields that matched their left-sided counterparts ([Fig. 6A ii, white arrowhead](#f0006){ref-type="fig"}). We also observed punctate dots of *Xnr-1* expression in injected embryos that were located outside of the normal Xnr-1 field including: along the midline ([Fig. 6A, iii red arrowhead](#f0006){ref-type="fig"}), in the posterior, and along the flanks of embryos. This ectopic, spotty *Xnr-1* expression outside of the lateral plate mesoderm ranged from one or 2 punctate areas of expression to multiple spots. To our knowledge, this is the first report of ectopic, punctate *Xnr-1* expression, as other previous studies report only the presence of bilateral expression or reversed, right-sided expression in response to genetic manipulations.[@cit0049]

Lefty is another patterning gene, which is activated by Xnr-1 and acts to limit the spatial distribution and duration of Xnr-1 signaling.[@cit0052] Its left-sided expression acts as a barrier to Xnr-1 at the midline, preventing the transduction of "left" signals to the right half of the body. *Lefty* is expressed throughout organogenesis, propagating the polarity established by Xnr-1 through interactions with other downstream factors such as *Pitx2* and *BMP-4*.[@cit0053] To determine if HCN4 regulates the spatial organization of *Lefty* expression in a similar fashion to *Xnr-1*, we investigated *Lefty* expression at stages when both *HCN4* and *Lefty* transcripts are present in the cardiac mesoderm (NF stage 27, [Figs. 1](#f0001){ref-type="fig"} and [7](#f0007){ref-type="fig"}, respectively). Both overexpression and injection of the dominant-negative mRNA resulted in bilateral *Lefty* expression. As observed with *Xnr-1*, there was a range in the severity of bilateral expression. Some embryos had a partial second *Lefty* field with a gap in expression along the midline ([Fig. 7A](#f0007){ref-type="fig"}, [ii](#f0007){ref-type="fig"}). However, in other embryos, *Lefty* expression appeared extremely disorganized and encompassed a large area of the anterior-ventral surface of the animal, including the midline ([Fig. 7A](#f0007){ref-type="fig"}, [iii](#f0007){ref-type="fig"}). All injection conditions generated significantly higher percentages of abnormal *Lefty* expression compared with uninjected sibling controls ([Fig. 7B](#f0007){ref-type="fig"}, χ^2^ = 19.0086, df = 4, p \< 0.05). There was no statistical difference between overexpression, dominant-negative or sidedness of injection. Figure 7.Altering normal HCN4 expression results in aberrant *Lefty* expression. (A) As visualized via *in situ* hybridization analysis, *Lefty* is normally expressed unilaterally in the left lateral plate mesoderm in NF stage 27 embryos (i). Altering HCN4 expression induced both full or partial bilateral and abnormal *Lefty* expression but did not result in a complete reversal of expression (solely right-sided). One of the most frequently observed bilateral phenotypes was a partial secondary field on the right side of embryos with the midline maintained by an absence of *Lefty* expression (ii). In the other commonly seen phenotype, *Lefty* transcripts were expressed across the anterior ventral surface of animals in an undefined shape with no visible midline gap (iii). Images are ventral views with anterior at top. (B) Overexpressing HCN4 and HCN4-DN(AAA) injection led to significant percentages of abnormal embryos compared with uninjected embryos (χ^2^ = 19.0086, df = 4, \*p \< 0.05). There was no statistical difference between overexpression and dominant-negative phenotypes. n = 56--71 embryos per condition across 3 biological replicatesOE = HCN4-OE, DN = HCN4-DN(AAA). Scale bars = 200 μm.

After axis-patterning genes such as Xnr-1 and Lefty help to establish sidedness in the body, organ morphogenesis must also be carefully regulated such that final organ asymmetry occurs correctly. Two critical mediators of these events, Pitx2 and BMP-4, directly translate asymmetric gene expression into asymmetric morphogenesis in multiple species through independent and coordinated interactions.[@cit0053] Both *Pitx2* and *BMP-4* are regulated by Xnr-1 signaling, and work together to impart laterality to the developing heart tube.[@cit0056] Both of these genes are asymmetrically expressed along the left side of the heart tube, providing laterality to the tube just before the onset of rightward looping. Because misexpression of either gene leads to severe positional defects in embryonic hearts, we examined the expression of *Pitx2* and *BMP-4* in HCN4-OE and HCN4-DN(AAA) injected embryos.

To characterize the relationship of HCN4 expression to *Pitx2* expression, we examined NF stage 27 embryos in HCN4-OE and HCN4-DN(AAA) injected animals. Both overexpression and injection of the dominant-negative construct resulted in significantly higher percentages of abnormal *Pitx2* expression patterns compared with uninjected sibling control animals ([Fig. 8](#f0008){ref-type="fig"}, χ^2^ = 64.71, df = 4, \*p \< 0.05). There was no statistical difference between the overexpression and dominant-negative conditions, or sidedness of injection, all of which resulted in altered *Pitx2* expression. Phenotypes included an expansion or reduction in the size of the endogenous field and bilateral expression ([Fig. 8A](#f0008){ref-type="fig"}, [ii](#f0008){ref-type="fig"}, [iii](#f0008){ref-type="fig"}, [v](#f0008){ref-type="fig"}). Similar to the *Xnr-1* and *Lefty* results, the bilateral fields were not always equivalent in size. Many embryos had only a small, partial field on the right side of the body in addition to the endogenous field. No animals were observed to have a complete ablation of *Pitx2* expression. Figure 8.Altering HCN4 expression leads to improper distribution of the homeodomain transcription factor *Pitx2*. (A) *In* situ hybridization of representative embryos displaying normal and examples of the most commonly observed *Pitx2* expression defects. Uninjected embryos have asymmetric, left-sided expression (i lateral view; iv ventral view). Overexpression and injection of the dominant-negative construct resulted in a variety of molecular phenotypes including expansion or reduction of the endogenous field (ii, iii) and bilateral *Pitx2* expression (v). Anterior at top of images. (B) All manipulations caused significantly higher percentages of abnormal *Pitx2* expression compared with uninjected embryos (χ^2^ = 64.71, df = 4, \*p \< 0.05). There was no statistical difference between overexpression and dominant-negative phenotypes. n = 54--86 embryos per condition across 3 biological replicates. OE = HCN4-OE, DN = HCN4-DN(AAA). Scale bars = 200 μm.

Because *BMP-4* transcripts have a dynamic spatio-temporal pattern during critical stages of heart development and morphogenesis,[@cit0063] we examined its expression profile in injected embryos at 3 different stages of heart development: before the onset of looping (NF stage 27), during looping while expression is asymmetric in the myocardium (NF stage 32), and after the completion of cardiac looping (NF stage 35). In uninjected embryos, *BMP-4* has a bilateral, wing-shaped pattern beginning at NF stage 27 ([Fig. 9A](#f0009){ref-type="fig"}, [i](#f0009){ref-type="fig"}). This pattern becomes increasingly more distinct as looping progress with an area of asymmetric expression arising in the myocardium during these stages ([Fig. 9B](#f0009){ref-type="fig"}, [i](#f0009){ref-type="fig"}, [yellow arrow](#f0009){ref-type="fig"}). At the completion of looping (NF stage 35), the wing-pattern remains in the tissue surrounding the heart, and expression becomes more uniform around the outside layer of the myocardium ([Fig. 9C](#f0009){ref-type="fig"}, [i](#f0009){ref-type="fig"}). As [Fig. 9D](#f0009){ref-type="fig"} illustrates, all 3 stages investigated had significantly higher percentages of abnormal expression of *BMP-4* in injected animals (HCN4-OE and HCN4-DN\[AAA\]) compared with uninjected sibling controls (NF stage 27: χ^2^ = 32.4768, df = 4; NF stage 32: χ^2^ = 82.2366, df = 4; NF stage 35: χ^2^ = 36.0791, df = 4, All: \*p \< 0.05). Similar abnormal *BMP-4* expression phenotypes were observed in animals injected with the overexpression or the dominant-negative mRNA (no statistical difference between HCN4-OE and HCN4-DN\[AAA\] conditions, or left vs. right sided injections). Altering HCN4 function resulted in a global mispatterning of *BMP-4* expression that included either a reduction in *BMP-4* expression or loss of definition in the boundaries of the field ([Fig. 9A ii-iii](#f0009){ref-type="fig"}, [9B ii-iii](#f0009){ref-type="fig"}, [9C ii-iii](#f0009){ref-type="fig"}). There was no clear pattern in the location of reduction in embryos; *BMP-4* was reduced on either side or both sides in individual embryos. When there was a loss in field definition the canonical wing-shaped *BMP-4* pattern was no longer distinguishable; however, the area of *BMP-4* expression that lost definition was not consistent across individuals. Frequently, *BMP-4* expression was a disorganized smear across the ventral side, without wings or separation along the midline. We also observed a randomization or loss of asymmetric *BMP-4* expression in the myocardium at stage 32, which may have important implications for final heart morphology. Finally, by stage 35, although the majority of embryos had uniform *BMP-4* expression in the myocardium, heart looping was abnormal ([Fig. 9C ii-iii](#f0009){ref-type="fig"}). Figure 9.*BMP-4 expression* is reduced and incorrectly localized in response to altering HCN4 expression. (A) At NF stage 27 *BMP-4* is expressed in 2 bilateral patches around the developing heart field (i). Altering HCN4 caused a loss of definition to the fields (ii) as well as an overall reduction in the size of the fields and intensity of expression (iii). (B) *BMP-4* remains bilaterally expressed during heart looping (NF stage 32) with an additional asymmetric area of expression in the myocardium (yellow arrow, i). This left-sided myocardial expression helps to direct and orient heart looping. Overexpression of HCN4 and expression of HCN4-DN(AAA) not only disrupted the lateral *BMP-4* fields of expression (ii), it also caused both a randomization and loss of myocardial expression (white arrow, iii). (C) By the end of looping at NF stage 35, *BMP-4* is evenly expressed in the myocardium and retains its bilateral expression in the surrounding tissues (i). Similar to stage 27 and 32, disruption of HCN4 led to both a reduction in expression as well as a loss of field definition (ii, iii). Injected embryos frequently displayed malformed hearts who did not complete looping properly (yellow vs. white arrows). All abnormal images are from HCN4-DN(AAA) injected embryos but similar phenotypes were observed with HCN4-OE embryos. (A-C) Images are ventral views with anterior at top. (D) All stages and injection conditions induced significantly higher percentages of abnormal phenotypes compared with controls (Stage 27: χ^2^ = 32.4768, df = 4; Stage 32: χ^2^ = 82.2366, df = 4; Stage 35: χ^2^ = 36.0791, df = 4; All: \*p \< 0.05). There was no statistical difference between overexpression and dominant-negative phenotypes. n = 58--79 embryos per condition across 3 biological replicates. OE = HCN4-OE, DN = HCN4-DN(AAA). Scale bars = 200 μm.

Interestingly, the disruption of normal dorsal-anterior development, resulting in a reduction of anterior structures and loss of anterior notochord, results in abnormal heart left-right asymmetry.[@cit0064] During embryogenesis, Shh signaling helps to establish the dorsoventral axis, and patterns the midline, including the central nervous system and notochord.[@cit0065] Thus, to examine if the aberrant heart phenotypes observed in our experiments were due to a global mispatterning of the anterior, dorsal-midline, we examined the expression of Shh at several times during heart development. Embryos injected with HCN4-OE or HCN4-DN(AAA) were examined for *Shh* expression at 3 time points: during gastrulation, at the completion of neurulation, and during cardiac looping (Supplemental Figure 2B). In all stages examined, *Shh* expression was similar in uninjected control and injected animals suggesting the dorsal midline structures were not altered in these experiments.

Discussion {#s0003}
==========

Taken together, these data illustrate that altering HCN4 channel function during embryogenesis results in atypical positional orientation and morphogenesis of the heart. Importantly, the phenotypes observed in HCN4-DN(AAA) injected animals have a unique heart morphology when compared with what has been previously observed in studies that disrupted canonical laterality genes. For example, ectopic right-sided Xnr-1 expression randomizes heart situs but the hearts are still properly looped.[@cit0066] Similarly, overexpression of Lefty on either side of the body induces heart reversals (situs inversus) but proper looping and patterning is again maintained.[@cit0053] In contrast, overexpression of Pitx2 can cause reversal in heart laterality, straightened outflow tracts, and leads to chamber malrotation.[@cit0067] Likewise, inhibition of BMP-4 or its receptors results in a lack of cardiac looping and misplacement of the atria along the midline.[@cit0056] Remarkably, the phenotypes we observed in embryos where HCN4 expression is disrupted appear to be a combination of inappropriate signals during both the patterning of early embryonic fields as well as later events during cardiac morphogenesis such as looping ([Fig. 3](#f0003){ref-type="fig"}). It is important to note that these data also illustrate that heart mispatterning observed is not a matter of incorrect myocardial differentiation or gross morphological alteration of all organs and tissues. Both HCN4-OE and HCN4-DN(AAA) injected embryos expressed the mature myocardial protein, cardiac troponin-T, as well as the cardiac field marker *Nkx2.5*, indicating that differentiation occurred. In addition, the indistinguishable expression patterns of *Xbra, Otx2*, and *Shh* between injected animals and sibling controls suggest that HCN4 isn\'t arbitrarily disrupting axis formation, or germ layer specification, but rather it is specifically interacting with the genes that determine organ positioning.

Physiologically, only injection of HCN4-DN(AAA) significantly affected heart rate, with injected embryos displaying tachycardia. Tachycardia has also been described in human HCN4 loss of function mutations: a c-linker interaction mutant and a trafficking-defective mutant.[@cit0044] Importantly, both mutations occurred endogenously in patients, and the c-linker mutation was inherited across 4 generations of affected individuals. This suggests that the presence of a functioning HCN4 channel is required to properly pattern the cardiac conduction system, and this role is highly conserved across vertebrates; however, it is also possible that the abnormal heart rate is due to disrupted heart morphology or vice versa.

Our results demonstrating the altered expression of numerous morphogenetic control factors suggest a novel role for HCN4 during embryogenesis: coordinating the positional identity of cells needed to create functional organs via directing the distribution of important patterning molecules. The distribution of key signaling factors appears to be dependent on the correct function of HCN4 as both perturbations (overexpression and dominant-negative) induced similar phenotypes. Although *Lefty, Pitx2*, and *BMP-4* expression was disrupted in embryos overexpressing HCN4, it seems that embryos can somewhat compensate for these molecular aberrations because many of the embryos in those populations were able to form normal hearts. This form of compensation has recently been described in *Xenopus* organ laterality, where disruptions in upstream gene signaling did not always induce downstream changes in organ situs.[@cit0069] In sharp contrast, embryos with the dominant-negative construct ultimately have abnormal heart morphology, positioning and heart physiology. Combined, these data indicate that HCN4 channel function is required for the correct distribution of morphogenetic patterning genes during cardiogenesis, and contributes to directing final heart morphology. It should be noted that because *Xnr-1* is upstream of *Lefty, Pitx2*, and *BMP-4*, it is possible that HCN4 interacts with *Xnr-1* primarily, and subsequent changes in gene expression are a result of disrupted *Xnr-1* signaling.

These findings serve to expand the known roles of this important channel family, and reveal a new set of bioelectric inputs into cardiac organogenesis. This is not the first time an ion channel has been implicated in the distribution of patterning genes. For examples, during *Drosophila* wing formation, the inward rectifying potassium channel Irk2 is necessary for the correct dispersal of Dpp, the *Drosophila* homolog of BMP.[@cit0070] Knocking down the channel led to phenotypes that were similar to BMP mutant phenotypes, and reducing Dpp signaling exacerbated abnormal phenotypes. Similar developmental defects were also observed when the vertebrate homolog of the channel, Kir2.1, was disrupted during both *Xenopus* and mouse embryogenesis.[@cit0070] Again, the morphological defects were similar to those seen in defective TGFβ signaling. Taken together, these results combined with our study suggest that ion channel activity can play a significant role impacting gene expression patterns that feed into crucial aspects of embryogenesis.

One question that remains is how changes in ion channel function might instruct changes in the distribution of critical developmental genes. HCN4 could potentially regulate either the generation or the propagation of morphogenetic factors as altering its expression frequently led to a reduction in gene expression. Previous studies have shown that ion channels have reciprocal interactions with integrins found in the membrane, and these interactions affect downstream signaling responses.[@cit0073] In fact, in adult hearts HCN4 complexes with β~2~-adrenergic receptors to modulate the funny current and subsequent heart rate.[@cit0074] Therefore, it is possible that during embryogenesis fluxes through ion channels help to coordinate the distribution of ligands and receptors in the membrane that interact with morphogenetic proteins. For example, the BMP antagonist Noggin binds to heparin sulfate proteoglycans in cell membranes to modify the distribution of BMP, and this interaction can only occur within a specific concentration of Na^+^ present.[@cit0075] Potentially, channels such as HCN4 change the concentration of specific ionic species, altering not only membrane potential but also the localization, modification state, or interactions of critical transmembrane receptors. Likewise, modulation of resting potential by a variety of ion channels is known to regulate transcription of genes such as *Notch*[@cit0076] and of many other targets conserved from amphibian to human.[@cit0077] Many studies have also implicated bioelectrical control of the movement of small molecule signals (such as calcium, butyrate, and serotonin) that transduce voltage changes into second messenger cascades and alterations of transcription[@cit0039] of numerous downstream targets that are well-conserved among human and amphibian bioelectrical signaling responses.[@cit0079]

One other important hypothesis to consider is the importance of temporal, as well as spatial, patterning of bioelectrical activity. Numerous studies have shown HCN channels regulate membrane potential in a cyclical manner.[@cit0004] This type of clock-like signaling might be necessary in developing tissues to modulate patterning genes both spatially and temporally. This is consistent with a potential voltage threshold or cyclic pulsing of membrane potential that must occur to achieve correct positional identity; hypotheses that will be tested with further development of *in vivo* optogenetic tools that may allow a finer temporal dissection of ionic signaling in development.[@cit0080] Finally, although we have presented evidence that altering HCN4 expression during embryogenesis causes incorrect positioning of hearts, future studies are needed to dissect out the molecular mechanism and timing of this phenotype. Overall, the data presented here highlight a novel role for the clinically important HCN4 channel, and suggest early embryonic physiology as a tractable target for modulation of key development gene expression programs.

Materials and methods {#s0004}
=====================

Animal husbandry and embryo culture {#s0004-0001}
-----------------------------------

All animals were treated humanely and with regard for alleviation of suffering according to approved protocols (Institutional Animal Care and Use Committee Protocol Tufts University). Adult female *Xenopus laevis* were induced to ovulate via injection of chorionic gonadotropin hormone (Chorulon) and eggs were fertilized *in vitro*. After fertilization, eggs were dejellied in a 2% cysteine solution (pH 8) and reared in 0.1X Marc\'s Modified Ringer\'s solution (Stock solution: 10X MMR; 100 mM NaCl, 2 mM KCl, 1 mM MgCl~2~, 2 mM CaCl~2~, 5 mM HEPES, 10 μM EDTA, pH 7.4) at 14--18°C. Embryos and tadpoles were staged according to Nieuwkoop and Faber.[@cit0081]

Molecular cloning of constructs {#s0004-0002}
-------------------------------

A mouse HCN4-WT cDNA clone was kindly provided by Dr. Richard Robinson (Columbia University). Using a standard strategy for abolishing channel function by altering the highly conserved cation selectivity sequence in the pore domain (changed from GYG~349--351~ to AAA~349--351~;,[@cit0046] the HCN4-(AAA) mutant was generated in WT-HCN4 using primers: 5′ CACATGCTGTGCATTGAGGACGAACGTCAGGCA-3′ (forward) and 5′-TGCCTGA CGTTCGTCCTCAATGCACAGCATGTG-3′ (reverse). For recordings of *I*~HCN4~ currents in mammalian cell culture experiments, a WT or HCN4(AAA) mutant construct was sub-cloned into a bi-cistronic vector, pIRESGFP1 (a kind gift from Dr. David Johns, John Hopkins University), to create a CMVp-HCN4-IRES-eGFP fusion for subsequent expression studies. An empty vector pcDNA3 (Life Technologies, Grand Island, NY) was used as a negative control in electrophysiological recording experiments.

HCN4 constructs were used to transcribe HCN4-WT (overexpression \[OE\]) or HCN4-(AAA) (dominant negative) mRNAs for *Xenopus laevis* microinjection, both HCN constructs were subcloned into a pCS2 vector. The membrane-bound RFP that was microinjected as a lineage tracer was a gift from Dr. John Wallingford (University of Texas-Austin).

Cell culture, transfection and recording of I~HCN4~ currents {#s0004-0003}
------------------------------------------------------------

HEK293 cells were routinely maintained in Dulbecco\'s Modified Eagle\'s Medium supplemented with 10% fetal bovine serum, 100 ug/ml penicillin and 100 ug/ml streptomycin at 37°C as described previously.[@cit0084] Transfection was performed using a Fugene6 kit following manufacturer\'s instructions (Roche, Indianapolis, IN). For voltage clamping analysis, approximately 1×10^5^ cells were seeded in a 35-mm culture dish. 0.7 µg DNA was transiently transfected into HEK293 cells. In all experiments, the transfected cells were cultured for 24 hours to allow protein expression.

Whole cell-based HCN4 currents (*I*~HCN4~) were recorded from transfected HEK293 cells at room temperature as described previously.[@cit0085] The extracellular recording solution contained: 110mM NaCl, 0.5 mM MgCl~2~, 30 mM KCl, 1.8 mM CaCl~2~, and 5mM HEPES. Recording pipettes contained: 10 mM NaCl, 0.5mM MgCl~2~, 130 mM KCl, 5 mM HEPES, and 1mM EGTA. Cells expressing eGFP were subjected to voltage clamping measurements. *I*~HCN4~ was evoked in response to hyperpolarizing voltage steps to potentials between −60 and −130 mV from a holding potential of −40 mV. Data were collected by an Axopatch 200B amplifier interfaced to a Digidata 1322A acquisition system, and analyzed using a pCLAMP10 software package (Molecular Devices, Sunnyvale, CA).

Microinjection of mRNA into Xenopus embryos {#s0004-0004}
-------------------------------------------

Capped mRNAs were synthesized *in vitro* using the Sp6 mMessage Machine kit (Invitrogen). Cleavage stage embryos were injected in either the left or right blastomere at the 2-cell stage with mRNAs encoding either 350pg wild-type mouse *HCN4* (HCN4-WT) or 500pg dominant-negative mouse *HCN4* pore mutant (HCN4-DN\[AAA\]). Embryos injected with HCN4 mRNAs were co-injected with membrane-bound RFP (300pg) as a lineage tracer.

After microinjection into cleavage stage Xenopus embryos, embryos healed in 1X MMR overnight. Before the onset of gastrulation, the MMR was gradually reduced to 0.1X MMR, and embryos were raised in 0.1X MMR until they reached the desired stage, at which point they were sorted for fluorescent expression to confirm the presence and location of injected constructs. Prior to molecular analysis, embryos were killed with 5% tricaine (pH 7.2, MS-222, Acros Organics) and fixed for 1 hour at room temperature in MEMFA (0.1 M MOPS pH 7.4, 2 mM EGTA, 1 mM MgSO~4~, 3.7% formaldehyde).

Heart rate analysis {#s0004-0005}
-------------------

To determine if heart function was affected, the heart rate of 10 individual tadpoles per injection group was measured for a total of 30 embryos across 3 replicates. N.F. stage 46/47 tadpoles were lightly anesthetized in a petri dish with 0.1X MMR. 10-second videos of the beating hearts were recorded using a Canon RebelT5i camera. MPEG Streamclip software was used to reduce video speed for heart-rate analysis. Heart rates were calculated by dividing the number of beats by the time difference between the last and first diastole (when the ventricle is the least contracted). To account for replicate variation and differences in external factors such as season and room temperature, all experimental rates were normalized to the mean of control rates in each replicate.

In situ hybridization (ISH) {#s0004-0006}
---------------------------

The localization of mRNA transcripts was evaluated by whole-mount ISH as described previously.[@cit0087] Briefly, tadpoles were hybridized with digoxigenin-labeled antisense riboprobes, and expression was visualized using an anti-digoxigenin antibody conjugated to alkaline-phosphatase (Roche) and a purple BCIP/NBT precipitate. After the chromogenic reaction finished, embryos were fixed in MEMFA for 1 hour at room temperature or overnight at 4°C and either kept in 1X PBS at 4°C or dehydrated in 100% methanol for long-term storage at −20°C. Antisense RNA probes included: *BMP-4*,[@cit0088] *Pitx2*,[@cit0061] *Xnr-1*,[@cit0066] *Lefty*,[@cit0089] *Otx2*,[@cit0048] *Xbra, Shh*[@cit0090] and *HCN2* (*X. laevis hcn2.L* IMAGE clone 5514485, which was purchased from Dharmacon and a HindIII fragment was deleted, leaving exons 2--4 and part of exon 5 as probe). *HCN4* transcripts were detected using an antisense *HCN4* probe that was constructed as a synthetic DNA (Invitrogen) and cloned into vector PCRII Topo (Invitrogen). The synthetic sequence corresponded to parts of exon 1 and 3, and all of exon 2, of the RNA model Xelaev18020786m, of the gene annotated as *hcn4.S*, at position chr3S:59295253--59295679 of *X. laevis* genome build 9.1 (<http://www.xenbase.org>). The region synthesized was chosen because it had high similarity to homolog *hcn4.L*. Sense control probes were developed and tested to ensure the specificity of the probes.

Immunohistochemistry, immunofluorescence, and heart morphology scoring {#s0004-0007}
----------------------------------------------------------------------

Immunohistochemistry (IHC) and immunofluorescence was used to detect the localization of proteins in whole mount and on section. Euthanized tadpoles were permeabilized with PBTr (1X PBS, 0.1% Triton, 2 mg/ml bovine serum albumin \[BSA\]), blocked with 20% heat-inactivated goat serum in PBTr, and incubated with the primary antibody overnight at 4°C. After 5 hrs of PBTr washes, tadpoles were blocked and incubated overnight in goat anti-mouse IgG secondary antibodies conjugated to Alexa Fluor 555 (AF-555; 1:300; Invitrogen). Then, tadpoles were again washed in PBTr for 5 hours, rinsed in 1X PBS, and post fixed in MEMFA, for 1 hr. Protein expression was detected through fluorescence using a Zeiss Imager.M1 scope and Cy3 filter cube. For paraffin embedded sections, slides were first dewaxed in xylene, rehydrated through a series of ethanol washes, and then chromogenic IHC was performed as described previously.[@cit0091] Expression was detected through the presence of a purple precipitate from the chromogenic reaction. The following markers were assessed through IHC: CT3 (Developmental Studies Hybridoma Bank), HCN4 (Abcam ab69054), and HCN2 (Abcam ab84817). Hearts were examined for any aberrant phenotypes using a stringent scoring rubric that classified deviations from normal heart situs (in any direction) as abnormal, even if they were mild. Hearts were characterized as twisted when the chambers were displaced along the dorso-ventral (DV) axis. Rotated hearts were displaced along the left-right (LR) axis but in the same DV plane. Hearts were classified as unlooped when the outflow tract was improperly folded with respect to the ventricle.

Histology {#s0004-0008}
---------

For sectioning, dehydrated embryos were gradually transferred to 100% ethanol. Next, embryos were cleared in 2 subsequent 45-min Xylene washes and tissues were infiltrated with paraffin wax in 2 20-min incubations at 60°C. Embryos were then wax-embedded in molds and allowed to solidify overnight. Using a Leica 2255 rotary microtome, 10 or 15 µm sections were generated and fixed on Superfrost Plus glass slides. The slides were dewaxed using Xylene and mounted with Permount (Fisher Scientific). Sections were examined using a Nikon SMZ1700 microscope and pictures were taken using SpotIn-light Color Camera software.

Statistical analysis {#s0004-0009}
--------------------

All statistical analyses were performed using IBM SPSS statistics version 22 or R version 3.1.2, Pumpkin helmet.[@cit0092] For all categorical phenotype data, significance was assessed using a chi-square test (R, statistics package). In each chi-square analysis all abnormal categories were grouped into one to make it a binary comparison (normal vs. abnormal). The fifer package was used to analyze all pairwise comparisons in each chi-square test.[@cit0093] For heart rate data, significance was assessed using a Welch\'s test due to unequal variance in our data sets (SPSS).
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